A randomised double blind controlled trial of the effects of atorvastatin (80 mg) versus atorvastatin (10 mg) upon high sensitivity C reactive protein and interleukin-18 in ischaemic stroke and transient ischaemic attack patients

Trial Profile

A randomised double blind controlled trial of the effects of atorvastatin (80 mg) versus atorvastatin (10 mg) upon high sensitivity C reactive protein and interleukin-18 in ischaemic stroke and transient ischaemic attack patients

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Mar 2007

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Stroke; Transient ischaemic attacks
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top